Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas, Texas, USA.
mBio. 2013 Nov 19;4(6):e00721-13. doi: 10.1128/mBio.00721-13.
Tuberculosis, caused by Mycobacterium tuberculosis, remains a devastating human infectious disease, causing two million deaths annually. We previously demonstrated that M. tuberculosis induces an enzyme, heme oxygenase (HO1), that produces carbon monoxide (CO) gas and that M. tuberculosis adapts its transcriptome during CO exposure. We now demonstrate that M. tuberculosis carries a novel resistance gene to combat CO toxicity. We screened an M. tuberculosis transposon library for CO-susceptible mutants and found that disruption of Rv1829 (carbon monoxide resistance, Cor) leads to marked CO sensitivity. Heterologous expression of Cor in Escherichia coli rescued it from CO toxicity. Importantly, the virulence of the cor mutant is attenuated in a mouse model of tuberculosis. Thus, Cor is necessary and sufficient to protect bacteria from host-derived CO. Taken together, this represents the first report of a role for HO1-derived CO in controlling infection of an intracellular pathogen and the first identification of a CO resistance gene in a pathogenic organism.
Macrophages produce a variety of antimicrobial molecules, including nitric oxide (NO), hydrogen peroxide (H2O2), and acid (H+), that serve to kill engulfed bacteria. In addition to these molecules, human and mouse macrophages also produce carbon monoxide (CO) gas by the heme oxygenase (HO1) enzyme. We observed that, in contrast to other bacteria, mycobacteria are resistant to CO, suggesting that this might be an evolutionary adaptation of mycobacteria for survival within macrophages. We screened a panel of ~2,500 M. tuberculosis mutants to determine which genes are required for survival of M. tuberculosis in the presence of CO. Within this panel, we identified one such gene, cor, that specifically confers CO resistance. Importantly, we found that the ability of M. tuberculosis cells carrying a mutated copy of this gene to cause tuberculosis in a mouse disease model is significantly attenuated. This indicates that CO resistance is essential for mycobacterial survival in vivo.
由结核分枝杆菌引起的结核病仍然是一种毁灭性的人类传染病,每年导致 200 万人死亡。我们之前证明结核分枝杆菌诱导一种酶,血红素加氧酶(HO1),产生一氧化碳(CO)气体,并且结核分枝杆菌在 CO 暴露期间适应其转录组。我们现在证明结核分枝杆菌携带一种新的抗性基因来对抗 CO 毒性。我们筛选了结核分枝杆菌转座子文库中的 CO 敏感突变体,发现 Rv1829(一氧化碳抗性,Cor)的破坏导致 CO 敏感性显著增加。Cor 在大肠杆菌中的异源表达使其从 CO 毒性中恢复。重要的是,cor 突变体在结核病的小鼠模型中的毒力减弱。因此,Cor 是保护细菌免受宿主来源的 CO 的必要和充分条件。总之,这代表了 HO1 衍生的 CO 在控制细胞内病原体感染中的作用的首次报道,也是在致病性生物体中鉴定出 CO 抗性基因的首次报道。
巨噬细胞产生多种抗菌分子,包括一氧化氮(NO)、过氧化氢(H2O2)和酸(H+),用于杀死吞噬的细菌。除了这些分子之外,人源和鼠源巨噬细胞还通过血红素加氧酶(HO1)酶产生一氧化碳(CO)气体。我们观察到,与其他细菌不同,分枝杆菌对 CO 具有抗性,这表明这可能是分枝杆菌在巨噬细胞内生存的一种进化适应。我们筛选了一组约 2500 个结核分枝杆菌突变体,以确定在 CO 存在下生存所需的结核分枝杆菌基因。在这个小组中,我们确定了一个这样的基因,cor,它专门赋予 CO 抗性。重要的是,我们发现携带该基因突变拷贝的结核分枝杆菌细胞在小鼠疾病模型中引起结核病的能力明显减弱。这表明 CO 抗性对于分枝杆菌在体内的生存是必不可少的。